Pyridyl inhibitors of hedgehog signalling

Details for Australian Patent Application No. 2005282722 (hide)

Owner Genentech, Inc. Curis, Inc.

Inventors Malesky, Kimberly; Gunzner, Janet; Bao, Liang; Savage, Scott; Castanedo, Georgette; Sutherlin, Daniel; Reynolds, Mark; Wang, Shumei; Stanley, Mark; Lalonde, Rebecca; Dina, Michael

Agent Cullens

Pub. Number AU-B-2005282722

PCT Pub. Number WO2006/028958

Priority 60/607,367 02.09.04 US

Filing date 2 September 2005

Wipo publication date 16 March 2006

Acceptance publication date 3 March 2011

International Classifications

C07D 213/38 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/4418 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61P 35/00 (2006.01) Antineoplastic agents

C07D 213/40 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/56 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/70 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/75 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/81 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/82 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07F 9/142 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

29 March 2007 PCT application entered the National Phase

  PCT publication WO2006/028958 Priority application(s): WO2006/028958

3 March 2011 Application Accepted

  Published as AU-B-2005282722

28 April 2011 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 11 Apr 2011. Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000 2006

11 August 2011 Application for Amendment

  The nature of the amendment is: Amend the name of the inventor to read alesky, Kimberly; Gunzner, Janet; Bao, Liang; Savage, Scott; Castanedo, Georgette; Sutherlin, Daniel; Reynolds, Mark; Wang, Shumei; Stanley, Mark; Lalonde, Rebecca; Dina, Michael and Koehler, Michael F. T.. Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000

18 August 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 11 Apr 2011

24 November 2011 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Malesky, Kimberly; Gunzner, Janet; Bao, Liang; Savage, Scott; Castanedo, Georgette; Sutherlin, Daniel; Reynolds, Mark; Wang, Shumei; Stanley, Mark; Lalonde, Rebecca; Dina, Michael and Koehler, Michael F. T.

1 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005282726-1-alkoxy 1H-imidazo ring systems and methods

2005282721-4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms